Stephen Chang

Dr. Stephen Chang serves on the Scientific Advisory Board or Board of Directors for GT Biopharma, Orpheus Therapeutics, Cloak Therapeutics, Aegis Therapeutics, and Legacy Therapeutics.

Dr. Chang founded Stemgent, Inc. in 2008 and served as the Company’s Chief Scientific Officer. He has been involved in Viagene, Chiron, and Canji/Schering Plough in the area of gene and cancer therapy.

Dr. Chang received his Ph.D. in biological chemistry, molecular biology, and biochemistry from the University of California, Irvine, and an undergraduate BS from the University of Michigan.